[Sorin-Pericarbon pericardial bioprosthesis. A 4-year follow-up study].
Between January 1986 and December 1986, 106 Sorin-Pericarbon (new prostheses made of bobine pericardium) valves were implanted by our group: the object of this paper is to report the medium-term results of this new bioprosthesis. The probability of degeneration-free function at 4 years was 96.5 +/- 3.7% in patients with aortic valve replacement; the probability of reoperation-free survival for all patients was 95.2 +/- 3.3% and 96.5 +/- 3.7% for patients with aortic valve replacement with this prosthesis. The results of this new Sorin-Pericarbon bioprosthesis at medium-term are satisfactory and need to be confirmed at long-term by further follow-up.
Wallnberger
E
E
Service de chirurgie cardiovasculaire, hôpital de la Pitié-Salpêtrière, Paris.
Jault
F
F
Fontanel
M
M
Nataf
P
P
Cantoni
M
M
Pavie
A
A
Cabrol
C
C
Gandjbakhch
I
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000601:surgery; D001705:Bioprosthesis; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis / Q000009:adverse effects / Q000295:instrumentation / Q000401:mortality; D006801:Humans; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000601:surgery; D010496:Pericardium
Bioprothèses péricardiques de Sorin-Péricarbon. Suivi à 4 ans.